Pharmadule’s scope comprises design, fabrication, installation and validation of a complete biotech production facility.
Pharmadule said that its modular concept allows 80% of the construction to be completed in its workshop resulting in a very high and predictable quality, a short delivery schedule and financial benefits for the customers.
The facility is expected to be delivered to Sicor Biotech’s site for installation, qualification and hand over to the client by January, 2011. It will be delivered according to EU and US quality standards, and is the second complete Biotech Facility delivered by Pharmadule to Sicor Biotech.